Glaxosmithkline | DEBITO



Debt Cambiamento Data
AbbVie USD 69.89B 2.74B 2025-03
Amgen USD 56.2B 1.18B 2025-06
AstraZeneca USD 32.84B 1.19B 2025-06
Aurora Cannabis CAD 100.98M 11K 2024-12
Bausch Health Companies USD 21.74B 228M 2025-06
Bristol-Myers Squibb USD 50.93B 1.22B 2025-06
Canopy Growth CAD 489.67M 123.85M 2024-12
Corcept Therapeutics USD 6.6M 6.6M 2025-06
Drreddys Laboratories INR 51.08B 2.55B 2024-12
Eli Lilly USD 39.9B 1.39B 2025-06
GlaxoSmithKline GBP 17.35B 1.08B 2025-06
Glaxosmithkline GBP 16.99B 927M 2024-12
J&J USD 52.25B 15.62B 2025-03
Merck USD 34.84B 2.27B 2025-03
Novartis USD 31.27B 12M 2025-03
Pacira USD 580.49M 2.88M 2025-06
Perrigo USD 3.65B 24.4M 2025-06
Pfizer USD 60.93B 1.18B 2025-06
Prestige Brands USD 1.04B 27.25M 2025-06
Roche Holding CHF 34.44B 5.23B 2024-06
Sanofi 22.28B 1.24B 2025-06
Supernus Pharmaceuticals USD 31.77M 531K 2025-06
Takeda JPY 4.51T 9.32B 2025-06
Teva Pharmaceutical Industries USD 17.52B 872M 2025-06
Zoetis USD 6.79B 214M 2025-06


Glaxosmithkline DEBITO - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Aug 2025.